All In Biotech

Drug Trial Radar · NCT04418765

A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments

Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study With an Extension Period to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Patients With Unsuccessful Prior Preventive Treatments

Last checked: Nov 20, 2026Latest source record: Sep 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 892 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

892

Actual

Start

Jun 1, 2020

Primary completion

Jul 15, 2021

Study completion Sep 15, 2022

Sponsor

Lead sponsor
H. Lundbeck A/SIndustry
Sponsor type
Industry
First posted
Jun 5, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluation of eptinezumab in the prevention of migraine in participants with unsuccessful prior preventive treatments.

Conditions

  • Migraine

Interventions

  • EptinezumabDrug

    Eptinezumab, concentrate for solution for infusion 100 mg/milliliter (mL)

  • PlaceboDrug

    concentrate for solution for infusion, intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Number of Monthly Migraine Days (MMDs) Averaged Over Weeks 1 to 12Time frame: Baseline, Weeks 1 - 12

Locations

138 sites in 17 countries. Site status is shown where the registry gives one.

  • Diablo Clinical Research

    Walnut Creek, California

  • Sarkis Clinical Trials - Gainesville

    Gainesville, Florida

  • Accel Research Sites - Maitland

    Maitland, Florida

  • Michigan Headache and Neurological Institute

    Ann Arbor, Michigan

  • Clinical Research Institute Inc. - Minneapolis

    Minneapolis, Minnesota

  • Albuqerque Clinical Trials

    Albuquerque, New Mexico

  • Dent Neurologic Institute - Amherst

    Amherst, New York

  • Integrative Clinical Trials

    Brooklyn, New York

  • CTI Clinical Research Center

    Cincinnati, Ohio

  • Hometown Urgent Care & Occupational Health/Hometown Research - Huber Heights

    Dayton, Ohio

  • Lynn Health Science Institute - Oklahoma City

    Oklahoma City, Oklahoma

  • Clinical Neuroscience Solutions - Memphis

    Memphis, Tennessee

  • Northwest Clinical Research Center (NWCRC)

    Bellevue, Washington

  • Northwest Neurological

    Spokane, Washington

  • Universitair Ziekenhuis Brussel

    Brussels, Brussels Capital, Belgium

  • Jessa Ziekenhuis - Campus Virga Jesse

    Hasselt, Limburg, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Oost-Vlaanderen, Belgium

  • Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan

    Bruges, West-Vlaanderen, Belgium

  • Multiprofile Hospital for Active Treatment Heart and Brain EAD

    Pleven, Bulgaria

  • Medical Center - Teodora EOOD

    Rousse, Bulgaria

  • Acibadem City Clinic Tokuda Hospital

    Sofia, Bulgaria

  • Medical Center Medica Plus

    Veliko Tarnovo, Bulgaria

  • Multiprofile Hospital for Active Treatment in Neurology and Psychiatry Sveti Naum

    Sofia, Sofia-Grad, Bulgaria

  • First Multiprofile Hospital for Active Treatment - Sofia

    Sofia, Sofia-Grad, Bulgaria

  • Nemocnice Jihlava

    Jihlava, Czechia

  • Neurosanatio s.r.o

    Litomyšl, Czechia

  • Neurologie, MP-neuro s.r.o., poliklinika Modry pavilon

    Slezská Ostrava, Czechia

  • NeuroMed Zlín s.r.o.

    Zlín, Czechia

  • MUDr. Helena Hojdíkova s.r.o. Neurologicka Ambulance

    Hradec Králové, Hradec Kralové, Czechia

  • Vestra Clinics

    Rychnov nad Kněžnou, Hradec Kralové, Czechia

  • CCR Brno

    Brno, Jihormoravsky Kraj, Czechia

  • Fakultni nemocnice Ostrava

    Ostrava-Poruba-Poruba, Moravian-Silesian, Czechia

  • CCR Prague

    Prague, Prague, Czechia

  • Fakultní Thomayerova nemocnice

    Prague, Prague, Czechia

  • Neurologicka Ambulance - Forbeli

    Prague, Prague, Czechia

  • Neuropsychiatrie S.R.O.

    Prague, Prague, Czechia

  • Institut Neuropsychiatrické Péce

    Prague, Prague, Czechia

  • CCR Ostrava

    Ostrava, Severomoravsky Kraj, Czechia

  • Fakultní Nemocnice u sv. Anny v Brne

    Brno, South Moravian, Czechia

  • Sydvestjysk Sygehus - Esbjerg

    Esbjerg, Denmark

Showing 40 of 138 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.